| Justin Etzel, MD | |
|
1011 Valley River Way Ste 110, Eugene, OR 97401-2127 | |
| (541) 762-2763 | |
| Not Available |
| Full Name | Justin Etzel |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 6 Years |
| Location | 1011 Valley River Way Ste 110, Eugene, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588168488 | NPI | - | NPPES |
| 500807814 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD208110 (Oregon) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sterling Vision Pc | 3173773694 | 7 |
News Archive
More than 50 million Americans suffer from sleep disorders, and diseases including Parkinson's and Alzheimer's can also disrupt sleep.
Ziath has posted a new video that provides an easy-to-follow guide to assist scientists and technicians scanning and decoding sample tube racks direct from low-temperature storage.
Amarantus BioSciences, Inc., a biotechnology company developing new treatments for brain-related disorders including traumatic brain injury (TBI) based on its proprietary anti-apoptotic therapeutic protein known as MANF and Banyan Biomarkers, the leader in developing in vitro diagnostic products to detect TBI, today announced the successful completion of a collaboration agreement initiated in November 2011 to evaluate MANF's potential as a disease-modifying agent for the treatment of TBI.
Merz Pharmaceuticals today announced that the United States Food and Drug Administration has approved Xeomin (incobotulinumtoxinA), a botulinum toxin type A for the treatment of adults with cervical dystonia or blepharospasm. According to an epidemiology study conducted in Rochester, Minnesota, the prevalence of focal dystonia, which includes cervical dystonia and blepharospasm, is estimated at 295 per million people in the U.S.
Fashion designer Kate Spade's death Tuesday has reminded Americans of the enormous toll of suicide, a growing problem that claims nearly 45,000 lives a year.
› Verified 9 days ago
| Entity Name | Sterling Vision Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902161946 PECOS PAC ID: 3173773694 Enrollment ID: O20121018000464 |
News Archive
More than 50 million Americans suffer from sleep disorders, and diseases including Parkinson's and Alzheimer's can also disrupt sleep.
Ziath has posted a new video that provides an easy-to-follow guide to assist scientists and technicians scanning and decoding sample tube racks direct from low-temperature storage.
Amarantus BioSciences, Inc., a biotechnology company developing new treatments for brain-related disorders including traumatic brain injury (TBI) based on its proprietary anti-apoptotic therapeutic protein known as MANF and Banyan Biomarkers, the leader in developing in vitro diagnostic products to detect TBI, today announced the successful completion of a collaboration agreement initiated in November 2011 to evaluate MANF's potential as a disease-modifying agent for the treatment of TBI.
Merz Pharmaceuticals today announced that the United States Food and Drug Administration has approved Xeomin (incobotulinumtoxinA), a botulinum toxin type A for the treatment of adults with cervical dystonia or blepharospasm. According to an epidemiology study conducted in Rochester, Minnesota, the prevalence of focal dystonia, which includes cervical dystonia and blepharospasm, is estimated at 295 per million people in the U.S.
Fashion designer Kate Spade's death Tuesday has reminded Americans of the enormous toll of suicide, a growing problem that claims nearly 45,000 lives a year.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Justin Etzel, MD 1011 Valley River Way Ste 108, Eugene, OR 97401-2184 Ph: (541) 249-9309 | Justin Etzel, MD 1011 Valley River Way Ste 110, Eugene, OR 97401-2127 Ph: (541) 762-2763 |
News Archive
More than 50 million Americans suffer from sleep disorders, and diseases including Parkinson's and Alzheimer's can also disrupt sleep.
Ziath has posted a new video that provides an easy-to-follow guide to assist scientists and technicians scanning and decoding sample tube racks direct from low-temperature storage.
Amarantus BioSciences, Inc., a biotechnology company developing new treatments for brain-related disorders including traumatic brain injury (TBI) based on its proprietary anti-apoptotic therapeutic protein known as MANF and Banyan Biomarkers, the leader in developing in vitro diagnostic products to detect TBI, today announced the successful completion of a collaboration agreement initiated in November 2011 to evaluate MANF's potential as a disease-modifying agent for the treatment of TBI.
Merz Pharmaceuticals today announced that the United States Food and Drug Administration has approved Xeomin (incobotulinumtoxinA), a botulinum toxin type A for the treatment of adults with cervical dystonia or blepharospasm. According to an epidemiology study conducted in Rochester, Minnesota, the prevalence of focal dystonia, which includes cervical dystonia and blepharospasm, is estimated at 295 per million people in the U.S.
Fashion designer Kate Spade's death Tuesday has reminded Americans of the enormous toll of suicide, a growing problem that claims nearly 45,000 lives a year.
› Verified 9 days ago
Scott Cherne, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1125 Darlene Ln, Suite 100, Eugene, OR 97401 Phone: 541-343-5000 Fax: 541-344-9478 | |
Blake V Fausett, M.D Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2550 Willakenzie Rd, Eugene, OR 97401 Phone: 541-434-0922 | |
Walter Benjamin Kunz, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1550 Oak St, Suite 7, Eugene, OR 97401 Phone: 541-687-1927 | |
Dr. Anthony Grillo, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1125 Darlene Ln, Eugene, OR 97401 Phone: 541-343-5000 | |
Peter Wyzinski, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1125 Darlene Ln, Suite 100, Eugene, OR 97401 Phone: 541-343-5000 Fax: 541-344-9478 | |
Mr. Allan Armstrong Hunter Iii, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 360 S Garden Way Ste 101a, Eugene, OR 97401 Phone: 541-237-8400 Fax: 541-237-8850 | |
Matthew D Neale, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 992 Country Club Rd, Ste101, Eugene, OR 97401 Phone: 541-687-1715 Fax: 541-687-1690 |